Fortress Biotech Announces Receipt of Notice of Option Exercise from AstraZeneca to Fully Acquire Caelum Biosciences, a Company Founded by Fortress Biotech Sep 29, 2021
Mustang Bio Announces MB-101 (IL13Rα2‐targeted CAR T cells) Scientific Presentations at Upcoming Virtual Conferences Sep 28, 2021
Checkpoint Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference Sep 22, 2021
Fortress Biotech Reports Record Second Quarter 2021 Financial Results and Recent Corporate Highlights Aug 16, 2021
Mustang Bio Reports Second Quarter 2021 Financial Results and Recent Corporate Highlights Aug 16, 2021
